AGIO
Agios Pharmaceuticals Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $29.48
- Day High
- $29.83
- Day Low
- $29.2
- Day Open
- $29.44
- Volume
- 23683
- Day Change
- 0.9%
Latest news data for AGIO
Agios Pharmaceuticals (AGIO) presents at 41st Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:AGIO)
seekingalpha.com
Beta Thalassemia Clinical Trials Pipeline Analysis: 22+ Companies are Working to Improve the Treatment Space | DelveInsight
globenewswire.com
Sickle Cell Disease Treatment Market Size to Surpass Around USD 8.75 Billion by 2029 | Research Report by Fortune Business Insights
globenewswire.com
Agios Unveils 2023-2026 Value-driving Catalysts Enabling Company's Vision to Transform Patient Outcomes in Rare Diseases - Agios Pharmaceuticals (NASDAQ:AGIO)
benzinga.com
Agios Unveils 2023-2026 Value-driving Catalysts Enabling Company’s Vision to Transform Patient Outcomes in Rare Diseases
globenewswire.com
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer - Agios Pharmaceuticals (NASDAQ:AGIO)
benzinga.com
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer
globenewswire.com
Agios to Present at 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
globenewswire.com
Agios rare blood disorder drug Pyrukynd sustains benefits in long term data
seekingalpha.com
Agios Pharmaceuticals : View the 2021 Annual Report
marketscreener.com